< Back to search
Filter
1
Featured

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

for
Early Breast Cancer
Location: Sterling Heights MI, Fountain Valley CA
Sponsor: Genentech, Inc.

Sex: Female

Age: 18+

Code: NCT07541079

Phase3, Recruiting
Featured

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

for
Breast Cancer
Location: Montreal, Morgantown WV, Toronto, Germantown TN,
Sponsor: Hoffmann-La Roche

Sex: Female

Age: 18+

Code: NCT07054190

Phase2, Recruiting
Active & Responsive

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

for
Advanced Breast Cancer, Early Breast Cancer
Location: Westbury NY, The Bronx NY, New York NY, Amsterdam NY,
Sponsor: TerSera Therapeutics LLC

Sex: Female

Age: 18 - 55

Code: NCT07310420

Phase1, Recruiting
Active & Responsive

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

for
Breast Cancer Screening, Artificial Intelligence (AI)
Location: Boston MA, Miami FL, Madison WI, Seattle WA,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06934239

Recruiting
Active & Responsive

B.Brilliant Revelation Comparision Study

for
Breast Cancer Screening
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: Female

Age: 18+

Code: NCT07067788

Recruiting

Interested in new breast cancer, early breast cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

for
Breast Cancer Screening, Breast Carcinoma in Situ,
Location: New York NY, Miami FL, Birmingham AL, Chicago IL,
Sponsor: University of California, San Francisco

Sex: Female

Age: 30 - 70+

Code: NCT02620852

Recruiting
Active & Responsive

Bundled Cancer Screening and Genetic Services Navigation

for
Breast Cancer Screening, Colon Cancer Screening,
Location: Newark DE, Washington D.C. DC
Sponsor: Georgetown University

Sex: Female

Age: 45 - 70+

Code: NCT07228000

Recruiting
Active & Responsive

RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer

for
Cancer Related Cognitive Decline, Non-metastatic Breast Cancer
Location: Hackensack NJ, Washington D.C. DC
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT05256745

Phase1, Phase2, Recruiting
Active & Responsive

Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer

for
HER2-positive Early-stage Breast Cancer
Location: Long Branch NJ, Toms River NJ, Elizabeth NJ, Newark NJ,
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT07402473

Phase2, Recruiting
Active & Responsive

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

for
Breast Cancer, Breast Neoplasm, Breast Tumor,
Location: New York NY, Hampton VA, Baltimore MD, Fairfax VA,
Sponsor: Proton Collaborative Group

Sex: Female

Age: 50+

Code: NCT01766297

Phase2, Recruiting
Active & Responsive

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

for
Breast Cancer, Liquid Biopsy, Early Detection
Location: Phoenix AZ
Sponsor: Syantra Inc.

Sex: Female

Age: 30 - 70+

Code: NCT07219277

Recruiting
Active & Responsive

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Gloucester MA, Beverly MA, Peabody MA, Winchester MA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05929768

Phase3, Recruiting
Active & ResponsiveNew

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

for
Triple Negative Breast Cancer (TNBC),
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07743190

Phase2, Recruiting
Active & Responsive

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

for
Breast Cancer Triple Negative, Breast Cancer Stage II,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT05877859

Recruiting
Active & Responsive

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for
Breast Neoplasms, Breast Cancer
Location: Norfolk VA, Nashville TN, Skokie IL, Houston TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06797635

Phase2, Recruiting

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

for
Breast Cancer, Early Breast Cancer
Location: Winston-Salem NC, Irving TX, Aberdeen SD, Pierre SD
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05774951

Phase3, Recruiting

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Location: Prince George
Sponsor: British Columbia Cancer Agency

Sex: Female

Age: 40+

Code: NCT06885671

Recruiting

JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year

for
Cardiovascular Health, Breast Cancer,
Location: Toronto
Sponsor: Women's College Hospital

Sex: All

Age: 18 - 70+

Code: NCT06930521

Recruiting

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Location: New Haven CT
Sponsor: Yale University

Sex: Female

Age: 18+

Code: NCT06917313

Phase2, Recruiting

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

for
Breast Cancer Early Stage Breast Cancer (Stage 1-3),
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: Female

Age: 25 - 70+

Code: NCT07387445

Recruiting